Colorectal Cancer Screening Market

Colorectal Cancer Screening Market Research,2032

Colorectal Cancer Screening Market is expected to surpass USD 29.10 billion by 2032 from USD 16.24 billion in 2021 at a CAGR of 6.8% in the coming years, i.e., 2022-32.

Bowel cancer and colon cancer are other names for colorectal cancer (CRC). It is the growth of cancer in the colon or rectum. With colonoscopy, a thorough diagnosis and effective therapy are possible without a big operation. The polyps can also be removed with a colonoscope. Adenomas, polyps, and illness signs can all be found using diagnostic processes employed in colorectal cancer screening tests in vitro. The large intestine, colon, and rectum exhibit aberrant cell proliferation in colorectal cancer, a medical disorder. The market for in colorectal cancer screening is anticipated to grow in response to the increased incidence of the disease.

Market Highlights

The Colorectal Cancer Screening Market is expected to project a notable CAGR of 6.8% in 2032.

Colorectal Cancer Screening Market is expected to surpass USD 29.10 billion by 2032 from USD 16.24 billion in 2021 at a CAGR of 6.8% in the coming years, i.e., 2022-32. The government's increased investment in R&D and the demand for early diagnoses are anticipated to fuel market expansion. Additionally, the market growth is boosted by the extensive research and development conducted by commercial and public organisations. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion.

Colorectal Cancer Screening Market: Segments

The Colonoscopy segment is expected to grow with a higher CAGR during 2022-32

Colorectal Cancer Screening Market is categorized on the basis of Screening Test into Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography and Colonoscopy. In 2021, the Colonoscopy segment held the highest this is due to the screening test's global ability to recognise and effectively eradicate both pro-malignant and malignant tumours.

The hospitals segment is expected to grow with a higher CAGR during 2022-32

Colorectal Cancer Screening Market is categorized on the basis of end user into Hospitals, Diagnostic laboratories and Others. The hospitals sector generated the largest revenue share in 2021 and had a profitable CAGR throughout the projection period. This is attributable to the rise in colorectal cancer cases and improvements in screening methods used in hospitals around the world. Independent diagnostic laboratories are anticipated to experience profitable CAGR growth during the predicted period. The reason for this is that there are now more tests being performed in these labs as a result of patients' growing knowledge of the advantages of early cancer detection.

Market Dynamics

Growth Drivers

Rising Cases of Cancer and Increased Use of Healthcare Equipment Is Driving Growth

The market for colorectal cancer screening tests is expected to be driven in the near future by the expansion of the patient pool due to the increased prevalence of cancer, industry requirements for minimally invasive disease diagnostics, and recent industry advances. The frequency of colorectal cancer among younger generations, which can occur for a variety of reasons, will further increase demand for colorectal screening tests. The introduction of various screening techniques to choose from taking the situation into consideration, the integration of genetic testing in cancer screening tests, as well as the introduction of regulations by authorities aiming to make cancer screening tests mandatory have all furthered the growth of this market.

Poor Eating Habits, Lifestyle Changes and Urban Air Pollution Are Expected to Surge Demand

Favorable regulations and DNA sequencing's affordability as a result of biotechnological developments will further support market expansion. Poor eating habits, lifestyle changes, an increase in smoking, genetic mutations, the use of hormones and alcohol, and urban air pollution are some of the common causes of the rising number of cancer patients worldwide. As a result, the market for colorectal cancer screening tests is growing significantly due to the rising incidence of cancer worldwide.

Restraint

Lack Of Experienced Workers and High Equipment Cost Is Likely to Hamper the Market Growth

The lack of experienced workers needed to handle devices and conduct research operations will provide substantial obstacles for the global industry for Colorectal Cancer Screening. Additionally, higher cost for equipment is also likely to hamper the global market.

Colorectal Cancer Screening Market: Key Players

• Sysmex Corporation

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Hemosure Inc
• Epigenomics Inc
• Novigenix SA
• Clinical Genomics Technologies
• Quidel
• Siemens
• GE Healthcare
• Abbott
• Exact Sciences
• Other Prominent Players

Colorectal Cancer Screening Market: Regions

Colorectal Cancer Screening Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In 2021, North America had the largest share in the market of Colorectal Cancer Screening. Government initiatives regarding promotion of efficient treatment facilities is also likely to promote growth in the North American region. Over the course of the forecast period, factors such the rising incidence of colorectal cancer, recommendations from government agencies for early screening, technical improvements, and the introduction of new products are projected to boost market expansion in the region of North America.

Colorectal Cancer Screening Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Colorectal Cancer Screening Market report also contains analysis on:

Colorectal Cancer Screening Market Segments:

• By Screening Test
  • Stool-Based Tests
  • Flexible Sigmoidoscopy
  • CT Colonography
  • Colonoscopy
• By End use
  • Hospitals
  • Diagnostic Laboratories
  • Others
• Colorectal Cancer Screening Market Dynamics
• Colorectal Cancer Screening Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Colorectal Cancer Screening Market Report Scope and Segmentation

Frequently Asked Questions (FAQ):